- The global cell therapy market is currently centered around the development and adoption of personalized therapies that use a patient’s own cells to treat various diseases, enhancing treatment precision and safety
- Increasing advancements in cell processing and manufacturing technologies are improving the scalability and accessibility of these therapies, allowing more patients to benefit from tailored treatment options
- North America dominates the cell therapy market with the largest revenue share of 58.12% in 2024, driven by advanced healthcare infrastructure and strong investment in research and development, which support rapid innovation and commercialization of new therapies
- Asia-pacific is expected to be the fastest growing region in the cell therapy market during the forecast period due to increasing urbanization, rising disposable incomes, and technological advancements.
- The autologous segment held the largest market revenue share in 2024, accounting for around 91.6% of the market. This dominance is driven by the use of a patient's own cells, which minimizes the risk of immune rejection and adverse reactions, leading to higher treatment efficacy and safety for personalized therapies
